
|Articles|June 8, 2015
Top Five Pharma CEO Paypackets Total More Than $100M
Author(s)News Update
June 8, 2015.
Advertisement
Looking at aggregated data from The New York Times, which used filings from the Securities and Exchange Commission to compute CEO compensation,
Motley Fool lists the five best-paid pharma CEOs as
- Lamverto Andriotti, BMS: $26.1 million
- Kenneth Frazier, Merck: $21.4 million
- Alex Gorksy, J&J: 20.4 million
- Ian Read, Pfizer: $18 million
- Richard Gonzalez, AbbVie: $17 million.
The key question, the reports asks, is "
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Johnson and Johnson Reveals Plan to Separate Orthopaedics Business
2
The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S.
3
The Evolving Landscape in Psychiatry: Challenges and Opportunities for Biopharma
4
Nabla Bio Enters $1 Billion Multi-Year Research Collaboration with Takeda
5